ABSTRACT The chromium content was measured in the lungs of chromate workers, obtained at necropsy in six patients and at surgery in two. The mean chromium content of peripheral lung tissue was 36-7 gg per gm wet weight (range 0 50 to 130-2 jg) and that of the large airways was 0-51 jg per gm wet weight (range 0-22 to 0 99 jg). These mean values were high compared with those from control lungs of a non-chromate exposed lung cancer patient-respectively 0-21 gg per gm in lung tissue and 0-1 Igg per gm in the large bronchi. The longer the exposure period, the higher was the chromium content in the lungs. The concentration of chromium in the upper lobes was sigfificantly higher than that in the lower lobes, suggesting regional differences either in clearance from or deposition in the lung. Moreover, it was apparent that the metal remained in the lungs long after exposure to chromate had ceased.
Chromate lung cancer has been recognised as one of the occupational diseases since the first report by Pfeil in 19351 and other reports in Germany and America. In Japan, chromate lung cancer was reported by Ohsaki in 1978.2 Although chromate compounds have been incriminated as carcinogens details of the exposure period for induction of lung cancer and of the chromate content in the body are not well documented. We measured the chromium content of the lungs, obtained at surgery and necropsy, of lung cancer patients who had worked in the chromate industry.
Methods
The lungs of eight chromate workers were obtained, in two cases at surgery and in six at necropsy (table 1) . All the patients were men and the average age was 58 5 years (range 50 to 72 yr). All but one patient had nasal perforation. Histology revealed squamous cell carcinoma in six cases, small cell anaplastic carcinoma in one case, and adenocarcinoma in one case. The mean latent period between the occurrence of lung cancer and leaving work was five years, ranging from 0 to 27 years.
After measuring the wet weight of lung tissue, cut into small pieces with a knife, 1 ml of nitric acid per gm was added to the tissue and heated to boiling point on a hot plate. Thereafter, it was mineralised with a mixture of nitric, sulphuric, and perchloric acids in the ratio of 3:1:1. After decomposition and drying, the sample was dissolved in 1 N nitric acid, then K2S04 was added and made into a 500 ppm solution to stabilise the chromium solution. Measurement solution of chromium was found. Recovery rate was from 107-7 to 115-3%. The difference between the chromium content of the liver and the standard solution would be the chromium present in normal liver. Analyses were repeated three times and the mean value was used. As a control, the lung of a non-chromate exposed lung cancer patient was analysed in the same way.
OCCUPATION OF SUBJECTS
The factory was small and the subjects had worked in all parts of the chromium industry. We divided the working place as in fig 1, II, III, and IV being the most hazardous for chromium dust exposure. We did not know exposure levels in individual subjects but they had worked in the industry for between eight and 32 years, with a mean exposure time of 24-6 years.
Results

CHROMIUM CONTENT OF THE LUNGS (TABLE 2)
The chromium content of airways, lung tissue, and tumour itself was markedly higher in the patients than the values in the control lung. Taking the right upper lobe, for instance, the mean concentration was 51-7 gg per gm wet weight, 114 times higher than the control value. In the right lower lobe, on the other hand, the mean content was 21-3 ytg per gm wet weight. Although this value was much higher than the control value of 0 3 Lg it was less than the concentration in the upper lobes. Although the chromium content of the large airways was higher than that of the control, the differences were not so striking as in the lung tissue. When the chromium concentration of the upper lobe was compared with that of the lower lobe, there was a significant difference (p<0-02, fig 2) .
RELATIONSHIP BETWEEN CHROMIUM CONTENT AND EXPOSURE PERIOD
The longer the period of exposure to chromates, the higher was the concentration of chromium in the lungs (fig 3) . This tendency was evident only in the lung tissue and not in the large airways. In the upper lobes the correlation between chromium content and exposure period was significant (r=0-831, p<001).
Discussion
Workers in the chromate industry are exposed to various dusts, such as chromate containing insoluble hexavalent chrome, in addition to lime and sulphuric acid during the process to the final 295 product. Inhaled dusts are cleared from airways by means of physical mechanisms at first. Dusts reaching the small airways are eliminated by mucociliary escalator and alveolar macrophages, but excessive amounts of dust may be deposited in the lungs. 4 In addition to the amount of dust, depressing of clearance mechanisms may be a factor in causing inhalational diseases. Our results reveal retention of chromium for a long time, even after leaving work. In one patient who had been away from the work place for 30 years, the chromium concentration was between two and nine times higher than the control value. Retention of chromium is mainly in the lung tissue. Concentration of chromium in the large airways is not so high nor is concentration in the tumour itself. Presumably expansion of the tumour would replace lung tissue containing concentrated chromium. Our patients were all heavy smokers, so that suppression of clearance mechanisms by smoking might have been a factor in the retention of chromium in the lungs. Smoking is an important factor in suppressing the clearance mechanisms, altering ciliary action, and the function of macrophages and pulmonary immunological defence mechanisms. 6 Soluble chromate containing hexavalent chrome is said to be more potent than insoluble trivalent chrome is a carcinogen.7 However, there are several reports questioning this and the problem is not solved yet.8 Our method measured chrome in the tissue as a whole, so that we could not investigate the difference in carcinogenicity of trivalent and hexavalent chrome. Our results indicate regional differences of chromium concentration in the lungs, the concentration being significantly higher in the upper lobes although the primary site of the lung cancer was mainly the 
